Gensight Biologics SA (SIGHT) — Net Asset Quality Index
Gensight Biologics SA (SIGHT) has a Net Asset Quality Index of -302.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €8.26 Million minus total liabilities of €33.20 Million yields net assets of €-24.94 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Gensight Biologics SA (SIGHT) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Gensight Biologics SA Net Asset Quality Index Over Time (2012–2025)
This chart shows how Gensight Biologics SA's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at -302.1%, representing net assets of €-24.94 Million against total assets of €8.26 Million EUR. For live market cap and overall valuation, see Gensight Biologics SA (SIGHT) market capitalisation.
Annual Net Asset Quality Index for Gensight Biologics SA (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Gensight Biologics SA from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check SIGHT PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -302.1% | €-24.94 Million | €8.26 Million | €33.20 Million | ▼ -51.8 pp |
| 2024 | -250.3% | €-26.92 Million | €10.76 Million | €37.68 Million | ▲ +85.9 pp |
| 2023 | -336.2% | €-30.70 Million | €9.13 Million | €39.83 Million | ▼ -277.3 pp |
| 2022 | -58.9% | €-15.28 Million | €25.94 Million | €41.22 Million | ▼ -87.1 pp |
| 2021 | 28.2% | €15.99 Million | €56.65 Million | €40.66 Million | ▲ +3.6 pp |
| 2020 | 24.6% | €11.67 Million | €47.36 Million | €35.69 Million | ▼ -11.5 pp |
| 2019 | 36.2% | €11.75 Million | €32.48 Million | €20.74 Million | ▼ -28.4 pp |
| 2018 | 64.6% | €23.87 Million | €36.98 Million | €13.11 Million | ▼ -23.9 pp |
| 2017 | 88.4% | €55.00 Million | €62.21 Million | €7.22 Million | ▼ -1.7 pp |
| 2016 | 90.1% | €53.34 Million | €59.23 Million | €5.89 Million | ▲ +9.3 pp |
| 2015 | 80.8% | €29.33 Million | €36.31 Million | €6.98 Million | ▲ +9.4 pp |
| 2014 | 71.4% | €10.58 Million | €14.82 Million | €4.24 Million | ▼ -18.5 pp |
| 2013 | 89.9% | €16.97 Million | €18.87 Million | €1.91 Million | ▲ +199.6 pp |
| 2012 | -109.7% | €-66.47K | €60.62K | €127.08K | — |